Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 318 | 542 | 0 | 0 | 2 |
Gross Profit | 318 | 542 | N/A | N/A | 2 |
Operating Expenses | 16,104 | 16,058 | 13,344 | 23,321 | 14,936 |
Operating Income | -15,786 | -15,516 | -13,344 | -23,321 | -14,934 |
Interest Expense | 711 | 2,757 | 1,840 | 2,592 | 2,703 |
Other Income | 22,895 | 14,132 | -543 | -47,540 | -166 |
Pre-tax Income | 6,398 | -4,141 | -15,727 | -73,453 | -17,803 |
Income Tax | -67 | 48 | -95 | 1 | 4 |
Net Income Continuous | 6,465 | -4,189 | -15,632 | -73,454 | -17,807 |
Net Income | $6,465 | $-4,189 | $-15,413 | $-73,454 | $-17,807 |
EPS Basic Total Ops | 0.18 | -0.14 | 0.08 | -4.89 | -1.47 |
EPS Basic Continuous Ops | 0.18 | -0.14 | 0.07 | -4.89 | -1.47 |
EPS Diluted Total Ops | -0.04 | -0.14 | 0.08 | -4.89 | -1.47 |
EPS Diluted Continuous Ops | 0.09 | -0.14 | 0.07 | -4.89 | -1.47 |
EPS Diluted Before Non-Recurring Items | N/A | -0.61 | -0.63 | -0.75 | -1.47 |
EBITDA(a) | $-15,336 | $-13,472 | $-12,752 | $-22,827 | $-14,385 |